- They are prohibitively expensive to administer.
- They are prohibitively expensive for consumers to purchase.
- They offer much less than optimal coverage, often with annual and lifetime limits, coverage gaps, and very high premiums and deductibles.
Republican lawmakers eager to repeal the Affordable Care Act are pushing tax credits and much greater freedom for states and health insurers to make healthcare-finance policy as the GOP starts to present its plan to replace the ACA.
The Republican program, which President Obama is expected to veto, would end ACA coverage requirements for individuals and employers, end expansion of Medicaid, kill state and HealthCare.gov federal insurance marketplaces and, indeed, end virtually everything else under the ACA, including taxes ”it imposes on medical devices and other things to finance enlarged coverage,” the Associated Press reported.
On Medicaid, the GOP plan would give states much more freedom in how to spend money in that federal-state pr0gram — even as more conservative states now seek the ACA’s added Medicaid money.
Given President Obama’s veto pen, we suspect that most of the Republican offensive is primarily rhetorical, leading up to the 2016 presidential election. And because the ACA has already developed powerful constituencies of beneficiaries, it’s far from clear how the GOP program will play politically in 2016, especially given that voter turnout is always higher in presidential-election years than in others.
”The roles and responsibilities of the two positions made working together difficult in the past,” John Byrnes, M.D., a board member of the Healthcare Financial Management Association and founder of the Byrnes Medical Group, told the news service.
“CMOs generally don’t have a business background, so they speak a different language than the CFO and vice-versa,” noted Dr. Byrnes, the former CMO of SCL Health, in Denver.
The disconnect includes building design. “You don’t really find finance offices close to clinical care, patient care areas,” he said.
But with the Affordable Care Act, Dr. Byrnes says, “CFOs are starting to realize that any improvement in care that the chief medical officer can drive through the organization also has significant financial benefits because more often than not it will remove some of the unnecessary costs in patient care out of the organization.”
Finding common ground benefits both the clinical and the financial sectors because it bridges the goals of lower costs and improved patient outcomes.
But a Reuters study suggested that these new entrants, while enthusiastic about getting preventive care, were no more likely than others to see the aforementioned pricey specialists. If anything, the study reminds us at Cambridge Management Group that the newly insured is boosting demand not only for primary-care physicians but also for nurse practitioners and physician’s assistants.
Reuters said that the profile of people covered by the Affordable Care Act exchanges came from ZocDoc, a free online appointment-booking tool used by millions of people in all 50 U.S. states.
”The data, covering thousands of users aged 18 to 64, suggests that ‘the vast majority who signed up in the first wave of Obamacare didn’t have acute medical needs, contrary to expectations,” Dr. Oliver Kharraz, ZocDoc’s co-founder and chief operating officer, told Reuters. ‘The biggest news here is the absence of dramatic utilization differences.”‘
Still, a caveat: ”The question is whether, over time, preventive care visits lead to more use of specialists,” Elizabeth Carpenter, director of the healthcare-reform practice at Avalere Health, told Reuters. “Obviously, the more individuals seek preventive care and screenings the more likely they are to be referred to a specialist.”
Mr. Shrinkman writes: “Few ordinary patients–the true bearers of change in healthcare policy–appear in this book, and virtually all of them came from the Time article {that Mr Brill wrote that was the basis of his book}. Mr. Shrinkman suggests that Mr. Brill is full of the hubris and social isolation of the “1 Percent” — as the gap between the very rich and everyone else widens.
Repeal of the ACA “is not a possibility,” George Scangos, chief executive at biotechnology company Biogen Idec Inc., told Reuters . “They {the Republicans} would somehow have to explain to millions of people that they will lose health insurance.”
Aetna Inc. said it is talking to Republicans and Democrats about a possible “grand bargain” to salvage the ACA if the U.S. Supreme Court rules against key elements of the law later this year.
“Blowing up the (Affordable Care Act) is like shutting down the government,” Aetna Chief Executive Officer Mark Bertolini told some investors. “So we are having conversations on both sides of the aisle about what … things you change in the ACA, what we could introduce, about how to make a grand bargain should the Supreme Court decide.”